Paper4580472
Efficacy and specificity of chenodeoxycholic acid therapy for dissolving gallstones.
Thistle JL and 1 other. N Engl J Med, 1973. Cited by 328 papers, by iCite.
Cite this record
ConductScience Library. Efficacy and specificity of chenodeoxycholic acid therapy for dissolving gallstones. Papers, record 4580472. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4580472
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bile Acids and Salts | Major topic |
| Cholelithiasis | Major topic |
| Aspartate Aminotransferases | |
| Chenodeoxycholic Acid | |
| Cholecystography | |
| Cholesterol | |
| Cholic Acids | |
| Clinical Trials as Topic | |
| Digestive System | |
| Female | |
| Humans | |
| Liver | |
| Liver Function Tests | |
| Male | |
| Placebos | |
| Solubility | |
| Time Factors | |
| Triglycerides |
Source PubMed
Cited by54
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 328 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40545045 | The history and future of bile acid therapies. | J Hepatol | 2025 | https://conductscience.org/library/papers/40545045 | PubMed |
| 31988099 | Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and Candida spp. | Antimicrob Agents Chemother | 2020 | https://conductscience.org/library/papers/31988099 | PubMed |
| 30936623 | Human-specific dual regulations of FXR-activation for reduction of fatty liver using in vitro cell culture model. | J Clin Biochem Nutr | 2019 | https://conductscience.org/library/papers/30936623 | PubMed |
| 29784843 | High Dose and Delayed Treatment with Bile Acids Ineffective in RML Prion-Infected Mice. | Antimicrob Agents Chemother | 2018 | https://conductscience.org/library/papers/29784843 | PubMed |
| 28729691 | Lowered fasting chenodeoxycholic acid correlated with the decrease of fibroblast growth factor 19 in Chinese subjects with impaired fasting glucose. | Sci Rep | 2017 | https://conductscience.org/library/papers/28729691 | PubMed |
| 25705637 | Recent advances in the development of farnesoid X receptor agonists. | Ann Transl Med | 2015 | https://conductscience.org/library/papers/25705637 | PubMed |
| 25646622 | Primary biliary acids inhibit hepatitis D virus (HDV) entry into human hepatoma cells expressing the sodium-taurocholate cotransporting polypeptide (NTCP). | PLoS One | 2015 | https://conductscience.org/library/papers/25646622 | PubMed |
| 25447797 | Impact of physiological levels of chenodeoxycholic acid supplementation on intestinal and hepatic bile acid and cholesterol metabolism in Cyp7a1-deficient mice. | Steroids | 2015 | https://conductscience.org/library/papers/25447797 | PubMed |
| 25214800 | Quantitative assessment of the multiple processes responsible for bilirubin homeostasis in health and disease. | Clin Exp Gastroenterol | 2014 | https://conductscience.org/library/papers/25214800 | PubMed |
| 23447519 | Cholic acid for hepatic steatosis in patients with lipodystrophy: a randomized, controlled trial. | Eur J Endocrinol | 2013 | https://conductscience.org/library/papers/23447519 | PubMed |
| 19429888 | Bile acids: developments new and very old. | J Lipid Res | 2009 | https://conductscience.org/library/papers/19429888 | PubMed |
| 18747563 | Medical treatment of cholelithiasis. | West J Med | 1975 | https://conductscience.org/library/papers/18747563 | PubMed |
| 17136860 | Isolation and determination of bile acids. | Eur J Drug Metab Pharmacokinet | 2006 | https://conductscience.org/library/papers/17136860 | PubMed |
| 7461466 | Chemical composition of gallstones resistant to dissolution therapy with chenodeoxycholic acid. | Gut | 1980 | https://conductscience.org/library/papers/7461466 | PubMed |
| 7374101 | Gallstone dissolution with chenodeoxycholic acid. A clinical study. | Klin Wochenschr | 1980 | https://conductscience.org/library/papers/7374101 | PubMed |
| 7076005 | Minimum effective dose of chenic acid for gallstone patients: reduction with bedtime administration and low cholesterol diet. | Gut | 1982 | https://conductscience.org/library/papers/7076005 | PubMed |
| 7075428 | Relationship between serum and biliary bile acids as an indicator of chenodeoxycholic and ursodeoxycholic acid-induced hepatotoxicity in the rhesus monkey. | Dig Dis Sci | 1982 | https://conductscience.org/library/papers/7075428 | PubMed |
| 7009140 | Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use. | Drugs | 1981 | https://conductscience.org/library/papers/7009140 | PubMed |
| 7000476 | Low-dose chenodeoxycholic acid for gallstone dissolution: a randomized trial in poor operative risk patients. | Dig Dis Sci | 1980 | https://conductscience.org/library/papers/7000476 | PubMed |
| 6986241 | Oral cholelitholysis--cheno versus urso: Japanese experience. | Dig Dis Sci | 1980 | https://conductscience.org/library/papers/6986241 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4580472
GET https://conductscience.org/api/papers/v1/4580472/cited_by?page=2